Product Manager, Commercial Neuroscience Portfolio
Spear Bio
Summary
Spear Bio is seeking a Commercial Product Manager to bridge our product strategy and commercial execution. Partnering with our internal Product Management, R&D, and Commercial teams, you will help bring our portfolio roadmap to market. You'll support key customers, present to key opinion leaders, and drive adoption of Spear Bio's best-in-class technology which includes assays, instruments, and custom assay services across neuroscience, with a focus on Parkinson's and Alzheimer's disease.
Job description
Summary
Spear Bio is seeking a Commercial Product Manager to bridge our product strategy and commercial execution. Partnering with our internal Product Management, R&D, and Commercial teams, you will help bring our portfolio roadmap to market. You'll support key customers, present to key opinion leaders, and drive adoption of Spear Bio's best-in-class technology which includes assays, instruments, and custom assay services across neuroscience, with a focus on Parkinson's and Alzheimer's disease.
Responsibilities
Cross-Functional Execution: Collaborate with R&D, Operations, Engineering, and Regulatory teams to guide new product concepts through validation, transfer, and launch. Develop a strong partnership with our Business Development, Assay Services, and Commercial FAS teams to support customer requirements and necessary tools to be utilized by the team.
Voice of the Customer (VoC): Develop a deep understanding of workflows in translational research and clinical trial markets, translating the needs of neuroscientists and biopharma clients into technical product specifications.
Commercialization & Launch: Partner with product marketing and global sales teams to establish product value proposition positioning, pricing models, and key collateral for high-impact international rollouts. Identify best funded institutions, and prioritize and support an outreach plan to gain opportunities in high revenue programs.
Track Progress and Market Requirements: Be the strategic voice of customer on Spear Bio solutions with a leadership role of key analytical information to formulate future strategy and support for our adoption plan.
KOL Engagement: Cultivate relationships with neuroscience Key Opinion Leaders (KOLs) and support data-generation collaborations developed and uncovered by our team. Established network and current contacts a big plus.
Market Expansion: Look for opportunities outside of the core market to build a growing application of our unique and best-in-class technology.
Qualifications & Requirements
Education: B.S. in Neuroscience, Biochemistry, Bioengineering, or Life Sciences required; Ph.D. or Master's degree preferred.
Experience: 3–5+ years of product management experience in the life science tools or diagnostics sector.
Domain Expertise: Strong background in digital immunoassays, protein biomarker discovery, or translational neurology research (e.g., Alzheimer's, TBI, neuroinflammation).
Skills: Excellent matrix-leadership capabilities, numerical commercial acumen, and the ability to articulate highly technical/scientific concepts to both engineers and customers.
Travel: Ability to travel up to 25% for customer site visits and major scientific conferences (e.g., Society for Neuroscience, AAIC).
Requirements
- B.S. in Neuroscience, Biochemistry, Bioengineering, or Life Sciences
- 3–5+ years of product management experience in life science tools or diagnostics
- Strong background in digital immunoassays, protein biomarker discovery, or translational neurology research
- Excellent matrix-leadership capabilities
- Numerical commercial acumen
- Ability to articulate highly technical/scientific concepts to engineers and customers
- Ability to travel up to 25%
Benefits
- Competitive compensation
- Stock ownership
- Comprehensive benefits
Company overview
Spear Bio is an innovative biotechnology company founded in 2021 and headquartered in Woburn, Massachusetts. The company specializes in developing ultra-sensitive protein biomarker detection technology for research and diagnostic applications. Spear Bio's proprietary Successive Proximity Extension Amplification Reaction (SPEAR) technology employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar levels from sub-microliter sample volumes. This breakthrough technology enables unprecedented sensitivity in detecting low-abundance biomarkers, particularly valuable for neurodegenerative disease research and early disease diagnosis. The company's SPEAR UltraDetect™ assays focus on neurological biomarkers including pTau 217, pTau 231, GFAP, and Neurofilament Light chain, with applications in Alzheimer's disease, traumatic brain injury, and other neurological conditions. Spear Bio recently secured FDA Breakthrough Device Designation for its pTau 217 blood test and raised $45 million in Series A funding to accelerate product commercialization and expand its biomarker menu.